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WastewaterWastewater treatment plants (WWTPs) are considered the main sources of chemicals of emerging concern
(CECs) in aquatic environments, and can negatively impact aquatic ecosystems. In this study,WWTP influent, ef-
fluent, and sludge, and upstream and downstreamwaters from theWWTP recipient were investigated at 15 lo-
cations for a total of 164 CECs, including pharmaceuticals, personal care products, industrial chemicals, per- and
polyfluoroalkyl substances (PFASs), and pesticides. In addition, zebrafish (Danio rerio) embryo toxicity tests
(ZFET) were applied to WWTP influent and effluent, and upstream and downstreamwaters fromWWTP recip-
ients. A total of 119 CECs were detected in at least one sample, mean concentrations ranging from 0.11 ng/L
(propylparaben) to 64,000 ng/L (caffeine), in wastewater samples and from 0.44 ng/L (ciprofloxacin) to
19,000 ng/L (metformin) in surface water samples. Large variations of CEC concentrations were found between
the selected WWTPs, which can be explained by differences in CEC composition in influent water and WWTP
treatment process. The sludge-water partitioning coefficient (Kd) of CECs showed a significant linear correlation
to octanol/water partition coefficient (KOW) (p < 0.001), and thus could be used for predicting their fate in the
aqueous and solid phase. The ΣCEC concentrations inWWTPs declined by on average 60%, based on comparisons
ofWWTP influent and effluent concentrations. The high concentrations of CECs inWWTP effluent resulted in, on
average, 50% higher concentrations of CECs in water downstream of WWTPs compared with upstream. Some
WWTP samples showed toxicity in ZFET compared with the respective control group, but no individual CECs
or groups of CECs could explain this toxicity. These results could provide a theoretical basis for optimization of
existing treatment systems of different designs, and could significantly contribute to protecting recipient waters.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Contamination of the aquatic environment by chemicals of emerging
concern (CECs), such as pharmaceuticals, personal care products, indus-
trial chemicals, per- and polyfluoroalkyl substances (PFASs), and pesti-
cides, has raised strong concerns due to their potential bioaccumulative
and toxic characteristics (Meyer et al., 2019; Petrie et al., 2015;
Sörengård et al., 2019). This rising concern derives from thewidespread
and growing use of CECs, but is also a consequence of improvements in
analytical techniques enabling detection of such substances at trace
levels (Dürig et al., 2019). Hundreds of thousands of tons of CECs are
dispensed and consumed annually worldwide and continuously re-
leased into the environment, albeit at low concentrations (Gago-
Ferrero et al., 2017; Petrie et al., 2015). CECs can be detected in various
environmental matrixes in trace concentration levels ranging from few
ng/L to several μg/L in water, sediments and biota (Dürig et al., 2020;
Golovko et al., 2020; Rehrl et al., 2020). Their fate and transport are
complex and dependent on numerous factors, such as production vol-
ume, consumption, disposal, removal and transformation atwastewater
treatment plants (WWTPs), stability (Caliman and Gavrilescu, 2009;
Debska et al., 2004; Fedorova et al., 2014; Golovko et al., 2014; Luo
et al., 2014; Petrie et al., 2015). CECs are nowubiquitous in groundwater
and surface water across the globe (Caliman and Gavrilescu, 2009;
Gago-Ferrero et al., 2015; Jones-Lepp and Stevens, 2007; Rogers, 1996;
Rostvall et al., 2018; Yang et al., 2017) and occur in complex mixtures
which can have adverse effects on the aquatic environment and its or-
ganisms (Carlsson et al., 2006; Carlsson et al., 2013). For example,
there are about 3000 different substances, used in human medication
in the EU, which are not regulated and often have shown to be environ-
mental persistent and are of toxicological concern (Fent et al., 2006).
Adverse effects that are frequently associated with the occurrence of
CECs in the aquatic environment are increasing antibiotic resistance of
microorganisms, acute or chronic toxicity, negative effects to non-
target organisms, uncertainties regarding transformation products and
metabolites and endocrine disrupting effects (Daughton and Ternes,
1999).
WWTPs have been shown to be the main sources of CECs in the
aquatic environment (Sörengård et al., 2019). Removal of CECs by
WWTPs generally depends on their physico-chemical properties
(Rostvall et al., 2018). Previous studies have found that removal of
CECs by conventional WWTPs is not sufficient, and that CECs can pass
through WWTPs and enter water systems (Gago-Ferrero et al., 2017;
Golovko et al., 2014; Sörengård et al., 2019). While the final effluent is
discharged into surface waters, the remaining residual sludge may be
incinerated, disposed at landfills, which can for instance lead to percola-
tion into groundwater, or applied as fertilizer to agricultural areas,
which pose a risk of run-off into water bodies (Luo et al., 2014; Yang
et al., 2017). WWTP effluents have a high impact on the occurrence of
CECs in thewater system, in particular in recipients with low or varying
water flows or recipients receiving wastewater from several or large
WWTPs (Blum et al., 2018; Gago-Ferrero et al., 2017). More knowledge
is needed on their removal efficiency inWWTPs and impact on recipient
water.
In order to assess risks of CECs in the aquatic environment, combined
use of analytical chemistry and toxicological bioassays is a suitable ap-
proach, especially when evaluating complex chemical mixtures such
as whole effluents and surface water samples. The combination of
chemical and toxicity evaluation is needed to fully understand the
risks caused by the presence of CECs in the aquatic environment. The
zebrafish (Danio rerio) embryo toxicity test (ZFET) has been used in var-
ious such applications, including toxicity testing ofmixtures of CECs and
sewage effluents (Menger et al., 2020; Pohl et al., 2020).
The aim of the present study was to assess the occurrence and re-
moval of 164 CECs in WWTPs and their impact on the receiving water
systems, using chemical characterization and toxicological evaluation.
Specific objectives were to: i) evaluate the removal efficiency of CECsin 15WWTPs in Sweden based onWWTP influent, effluent, and sludge;
ii) assess the impact of theWWTPs on the recipient water system com-
paring upstream and downstream waters from the WWTP recipients;
and iii) evaluate the toxicological effects of CECs in WWPT influent
and effluent and recipient water using ZFET. The ZFET was used for tox-
icological screening of water samples in combination with chemical
characterization of CECs to identify potential environmental impacts
of the WWTPs to the recipient water system.
2. Material and methods
2.1. Target CECs and chemicals
The target CECs were selected based on their occurrence and ubiq-
uity in the aquatic environment, as well as their production and con-
sumption volume (Caliman and Gavrilescu, 2009; Debska et al., 2004;
Luo et al., 2014; Petrie et al., 2015). The 164 CECs targeted comprised:
pharmaceuticals (n = 96), pesticides (n = 34), PFASs (n = 10),
parabens (n= 3), industrial chemicals (n = 9), personal care products
(n = 4), stimulants (n = 3), vitamins (n = 2), a drug (n = 1), a fatty
acid (n=1) and an isoflavone (n=1). Native standardswere acquired
from Sigma-Aldrich (Sweden). Isotopically labeled standards (ISs) (n=
26)were obtained fromWellington Laboratories (Canada), Teknolab AB
(Kungsbacka, Sweden), Sigma-Aldrich, and Toronto ResearchChemicals
(Toronto, Canada). All analytical standards used for analysis were of
high purity grade (>95%). Detailed information about native standards
and ISs can be found elsewhere (Gago-Ferrero et al., 2017; Sörengård
et al., 2019).
Ultrapure water was generated by a Milli-Q (MQ) Advantage Ultra-
pure Water purification system and filtered through a 0.22 μmMillipak
Express membrane and an LC-Pak polishing unit (Merk Millipore,
Billercia, MA). Methanol, acetonitrile, and formic acid of high analytical
grade were acquired from Sigma-Aldrich (Sweden).
2.2. Sampling
Influent and effluent wastewater samples were collected as 24-h or
one-week composite samples from 15 WWTPs in Sweden during June
2018 (Table S1 in Supporting Information (SI)). The WWTP sites were
selected based on a report by the Swedish Environmental Protection
Agency (SEPA), which identifiedWWTPs with potentially large impacts
on the receivingwater body (Wallberg et al., 2016). Surface water sam-
ples (0.1 m below the water surface) were collected (as grab samples)
in the recipient of WWTPs (both downstream and upstream of the
WWTP effluent entry point). All samples were collected into 1-L high-
density polyethylene bottles, immediately frozen, and stored frozen
(−20 °C) until analysis. Sludge samples were collected from dewatered
sludge at 14 WWTPs (Table S1 in SI).
2.3. Sample preparation for chemical analysis
Procedures used for preparation of water and sludge samples for in-
strument analysis are described in detail elsewhere (Fedorova et al.,
2014; Golovko et al., 2016). In brief, the wastewater and river water
samples were spiked with the IS mixture to achieve a concentration of
50 ng/L. The water samples were then filtered through a syringe filter
(0.45 μm, regenerated cellulose; Minisart® RC, Sartorius, Germany)
and 10mL aliquots were analyzed using a two-dimensional liquid chro-
matography (LC/LC) method coupled to tandem mass spectrometry
(MS/MS).
The sludge samples were prepared using an ultrasonic-based sol-
vent approach, for which detailed information can be found elsewhere
(Golovko et al., 2016). The sludge samples were air-dried overnight in
a clean fume hood. Before extraction, an IS mixture (c = 10 ng/g dw
sludge) was added to 2 g dry sludge sample. Then 4 mL of acetonitrile
andwater (1/1, v/v, 0.1% formic acid)were added to the air-dried sludge
3O. Golovko et al. / Science of the Total Environment 754 (2021) 142122and the samples were ultrasonicated for 15 min. The supernatant was
filtered through a syringe filter (0.45 μm, regenerated cellulose, VWR,
Sweden) into 10-mL vials. The step was repeated with a second extrac-
tion solvent mixture (acetonitrile, 2-propanol, and water (3/3/4 v/v/v
with 0.1% formic acid)). The two supernatants were combined, mixed
well, and 1 mL of the extract was used for analysis.
2.4. Instrumental analysis of CECs
The water and sludge samples were analyzed by a DIONEX UltiMate
3000 ultra-high pressure liquid chromatography (UPLC) system
(Thermo Scientific, Waltham, MA, USA) coupled to a triple quadrupole
mass spectrometer (MS/MS) (TSQ QUANTIVA, Thermo Scientific, Wal-
tham, MA, USA) (for details, see text in SI).
2.5. Quality control
The performance of the method was assessed with regard to its lin-
earity, limit of quantification (LOQ), precision, and blanks (for details
see text and Table S2 in SI). The physico-chemical properties of all target
compounds detected (n = 164) are shown in Table S3 in SI.
2.6. Fish embryo toxicity tests
Samples of influent and effluent from four WWTPs and water sam-
ples from their recipients (i.e., upstream and downstream of the
WWTPs) were toxicologically evaluated using the ZFET (n = 24 per
treatment). The testing included measurements of lethal and sub-
lethal responses in developing zebrafish embryos from fertilization up
to 6 days of age (for details, see text and Table S4 in SI) (Carlsson
et al., 2013). In addition, screening for acute toxicity using ZFETwas per-
formed on influent and effluent samples from sevenWWTPs and water
samples from their recipients.
The extraction of thewater samples (1L)was done using solid phase
extraction system (SPE-DEX, Horizon Technology, Salem, NH, USA)
using HLB extraction disks (Atlantic HLB-H Disks, diameter 47mm; Ho-
rizon Technology, Salem, NH, USA). In total, 1 L of thewater sample (in-
fluent, effluent and recipient waters) was automatically filtered and
loaded on the SPE disk which was pre-conditioned with methanol
(50 mL, 25 mL × 2) followed by Millipore water (25 mL × 2). Next,
the SPE disk was washed with 5% methanol (25 mL × 2) and then
Millipore water (25 mL × 2). The SPE disk was dried with nitrogen for
10 min at room temperature and finally eluted with methanol
(25 mL × 3). The TurboVap Classic II system (Biotage, USA) was used
for the evaporation until 0.5 mL at 40 °C in the 200 mL evaporation
tube, which was then rinsed with ethanol. The samples were further
concentratedwith solvent exchange to 0.5mL of ethanol. Finally the ex-
tractwas concentrated and the solventwas changed to dimethyl sulfox-
ide (DMSO) (concentration factor 2000).
The extracts were kept frozen at −20 °C until the day of exposure.
Each extract was diluted by mixing 20 μL of the extracted sample with
20,000 μL of carbon-filtered tap water in Petri dishes, resulting in 0.1%
solvent concentration in the exposure solution (concentration factor
two times the original water concentration). The embryos were ob-
served using stereo and invertedmicroscopes (Leica EZ4D andOlympus
CKX41) at 24, 48, and 144 h post-fertilization (hpf) for specific end-
points in three categories; lethal categorical, sublethal categorical, and
sublethal continuous (Table S1 in SI). The hatching time for each em-
bryo was recorded by a time-lapse camera (Canon EOS 500D) that
photographed the plates automatically every hour between 48 and
144 hpf. The hatching time for each individual embryo was determined
by visual examination of the time-lapse photos. At 144 hpf, embryo be-
havior was evaluated using an automated computerized video record-
ing system (ViewPoint Zebrabox®, ViewPoint, France). The swimming
activity of each embryo in the 96-well plates was automatically re-
corded in alternating dark and light phases. The assessment ofswimming activity began with 10 min of acclimation in light, followed
by three alternating 5-min dark and light intervals. The data on swim-
ming activity were evaluated in terms of three variables: total swim-
ming distance in darkness (mm/15 min), total swimming distance in
light (mm/15 min), and total swimming distance (mm/30 min).
2.7. Evaluation and statistics
The removal efficiency of individual CECs in the WWTPs was calcu-
lated as:




The sludge/water partitioning coefficient (Kd [L/ kg]) was calculated
as:






where cs is theCEC concentration in the sludge (csludge) and caq is theCEC
concentration in the aqueous effluent phase (csludge).
For chemical evaluation, octanol/water partition coefficient (KOW) of
the compounds was acquired from EPI Suite™ model (v. 4.11, USEPA,
USA) (Table S3 in SI). Partial Least Squares (PLS) using SIMCA 14.0 soft-
ware was used to identify relationships between the modeled physico-
chemical characteristics of the CECs (predictor variables (X)) and their
removal efficiencies and partitioning behavior (response variables
(Y)). The same PLS model was used to relate the measured chemical
composition (X) and ZFET score (from 0 to 3) (Y). Compounds with
no identified physiochemical characteristics and with concentrations
<LOQwere ignored. For a good PLS, R2X (PC1) should exceed 0.3 to ex-
plain enough of the variation in the data, and R2Y (PC2) should not ex-
ceed 0.4 because the risk of over-fit. After identifying important
variables, relationships between these variables were analyzed with
Pearson correlation, with significance level set to p < 0.05.
The toxicity data were analyzed using R Studio Version 1.1.463
(RStudio, Inc.). One-way ANOVA with Dunnet's post hoc test was used
to analyze the continuous ZFET endpoints. The binary data were ana-
lyzed using the Fisher exact test. One-way ANOVA with pairwise com-
parison was used to analyze the behavioral endpoints.
3. Results and discussion
3.1. Occurrence of CECs in wastewater influent and effluent, and in sludge
Of the 164 target CECs analyzed in wastewater influent and effluent,
119 contaminantswere detected inmost sample, including pharmaceu-
ticals, personal care products, industrial chemicals, PFASs, pesticides,
parabens, stimulants, and vitamins (Tables S5 and S6 in SI). The domi-
nant groups were NSAIDs (nonsteroidal anti-inflammatory drug), stim-
ulants, antidiabetic drugs, and industrial chemicals, whichwere present
at the highest concentrations in WWTP influent and effluent (Fig. 1).
Mean CEC concentrations detected for individual compounds in waste-
water samples showed high variation, ranging from ng/L tomg/L. Given
this wide range of concentrations, a noteworthy finding was that a
group of only 20 CECs was responsible for 70% of the combined concen-
tration of pollutants inWWTP influent and effluent (Tables S5 and S6 in
SI). These compoundswere not only present in high concentrations, but
had a high frequency of detection (>50%) (Fig. 2). The CECs included
three industrial chemicals (tetraethylene glycol, pentaethylene glycol
monododecyl ether (laureth-5) and di-(2-ethylhexyl)phosphoric acid
(DEHPA)), 15 pharmaceuticals (salicylic acid, diclofenac, losartan,
valsartan, venlafaxine, oxazepam, lamotrigine, carbamazepine, trama-
dol, HCTZ, theophylline, furosemide, ranitidine, bicalutamide, and met-
formin), and the stimulants caffeine and nicotine (Tables S5 and S6 in
Fig. 1. Combined concentrations of chemicals of emerging concern (CECs) in samples of influent and effluent from wastewater treatment plants in Sweden. NSAIDs – nonsteroidal anti-
inflammatory drugs, PFASs – per- and polyfluoroalkyl substances.
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those in other studies, which detected mainly pharmaceuticals, per-
sonal care products, and stimulants in wastewater and sludge samples
(Gobel et al., 2005; Kasprzyk-Hordern et al., 2009; Lajeunesse et al.,
2012; Yang et al., 2017). For example, Fick et al. (Fick et al., 2011) per-
formed a screening study in Sweden for 101 pharmaceuticals in waste-
water, surface water, sludge, and biota samples, and reported similar
concentration levels to those found for most pharmaceuticals analyzed
in the present study.
For individual CECs, the highest concentrations were found for met-
formin (up to 54,000 ng/L), caffeine (64,000 ng/L), and nicotine
(9600 ng/L) in wastewater influent and effluent. Metformin is by far
the most frequently prescribed antidiabetic drug worldwide and in
Sweden (Lindim et al., 2016). It has been shown that metformin is not
completely metabolized in the human body (Krentz and Bailey, 2005),
and is excreted unchanged and therefore released into the environment
via wastewater (Briones et al., 2016; Lindim et al., 2016; Scheurer et al.,
2009). Caffeine is widely consumedwith food and it has been suggested
that it could serve as a suitable wastewater indicator for river water, asFig. 2. Detection frequency of chemicals of emerging concern (CECs) present at frequency of de
surfacewater samples from Sweden. DMDEE – 2,2-dimorpholinyldiethyl-ether, 4-MBC – 3-(4-m
10-hydroxycarbamazepine, HCTZ – hydrochlorothiazide, BAM – dichlorobenzamide, DEHPA –presence of this compound in river water can be a strong indication of
wastewater contamination (Glassmeyer et al., 2005). Nicotine is
among the most widely used stimulants (besides caffeine) and is in-
cluded in tobacco, snuff, and other smoke-free tobacco products con-
taining nicotine (Ramström and Foulds, 2006) and widely detected in
the environment (Gago-Ferrero et al., 2017; Sörengård et al., 2019;
Yang et al., 2017). Furthermore, high concentrations of some metabo-
lites were found in effluent wastewater, such as metronidazole-OH at
up to 160 ng/L (metabolite of metronidazole), desmethylcitalopram at
up to 100 ng/L (metabolite of citalopram), desmethylvenlafaxine at up
to 1600 ng/L (metabolite of venlafaxine), and three of the main metab-
olites of the antiepileptic drug carbamazepine: D-H-CAR (up to
580 ng/L), carbamazepine 10,11-epoxyde (up to 400 ng/L), and
oxcarbazepine (up to 33 ng/L) (Tables S5 and S6 in SI). The occurrence
of the metabolites in the wastewater could originate from human ex-
creted metabolites or parent compounds can undergo biotransforma-
tion during wastewater treatment (Caliman and Gavrilescu, 2009;
Debska et al., 2004; Luo et al., 2014; Petrie et al., 2015). These results
show that it is important to monitor pharmaceutical metabolites/tection >50% in samples of influent and effluent fromwastewater treatment plants and in
ethylbenzylidene)camphor, DEET –N,N-diethyl-m-toluamide, D-H-CAR – 10,11-Dihydro-
di-(2-ethylhexyl)phosphoric acid.
Fig. 3. Combined concentrations of chemicals of emerging concern (CECs) in 14 sludge samples from wastewater treatment plants. NSAIDs – non steroidal anti-inflammatory drugs,
PFASs – per- and polyfluoroalkyl substances.
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et al., 2009; Petrie et al., 2015; Sörengård et al., 2019) and their toxicity
potential (Caliman and Gavrilescu, 2009; Carlsson et al., 2013) can be
higher than those of the parent compounds. For instance, a previous
study reported that carbamazepine 10,11-epoxyde, themain active car-
bamazepine metabolite, might have potential biological effects in non-
target species (Valdés et al., 2016).
Of the 164 target CECs, 103 were detected in sludge samples
(Tables S5 and S7 in SI). Analysis of sludge showed large variations in
concentrations betweenWWTPs (Fig. 3),which can be explained by dif-
ferences in CEC composition in the influent water and in operating
conditions at the WWTPs. Investigation of CECs in sludge is very
important, because in Sweden 25% of sludge is used for agricultural
purposes and 50% is used for landfilling or construction work (SEPA,
2013). The compounds with the highest frequency of detection
(>90%) and high concentrations (>100 ng/g dw) in sludgeweremainly
pharmaceuticals such as lamotrigine, venlafaxine, propranolol,fluoxetine,
carbamazepine, diclofenac, telmisartan, metoprolol, tramadol, cetirizine,
clozapine, metformin, mirtazapine, amitriptyline, bicalutamide, losartan,
fexofenadine, citalopram and itsmetabolite desmethylcitalopram, simva-
statin, budesonide, sertraline and its metabolite norsertraline (Tables S6
and S7 in SI). Similar results have been reported in a Swedish screening
study for metoprolol, mirtazapine, citalopram, amitriptyline, sertraline,
and telmisartan (Fick et al., 2011). For instance, psychoactive compounds
such as venlafaxine, fluoxetine, mirtazapine, amitriptyline, citalopram
and sertraline have a lipophilic nature and therefore have high affinity
to sludge (Horsing et al., 2011; Ivanová et al., 2018; Lajeunesse et al.,
2012). The concentration levels in sludge obtained in this study are in
agreement with previous studies on citalopram, fluoxetine and sertraline
in sludge (Fick et al., 2011; Ivanová et al., 2018).
It should be mentioned that seven pesticides (chloridazon,
fenpropimorph 4, dichlorprop (2,4-DP), fludioxonil, cyprodinil,
mandipropamid, and difenoconazole) were found only in sludge sam-
ples. These pesticides have a relatively high KOW (KOW > 3, except
chloridazon KOW = 1.1), and can thus be expected to be mainly sorbed
to soil, sediment, or sludge (Li, 2014) (Tables S3 and S6–7 in SI).
3.2. Removal efficiency of CECs in WWTPs
Overall, removal efficiencies varied significantly between the 164
CEC compounds (Fig. 4). Medium removal efficiency was calculated
for CECs that showed detection frequency > 50% (n = 86). Based onthe removal efficiency tendencies in WWTPs, CECs were divided into
two groups: positive removal efficiency (n=35) and negative removal
efficiency (n=48). TheΣCEC concentration declined by on average 60%
on comparingWWTP influent and effluent concentrations (Fig. 1). Sim-
ilar results have been reported for most pharmaceuticals in a previous
screening study (Fick et al., 2011). During wastewater treatment, CECs
can be removed (i.e., positive removal efficiency) through microbial
degradation or sorption to solids (Ternes et al., 2004), which are later
removed with the sludge. Negative removal efficiency, i.e., higher CEC
concentration in WWTP effluent compared with influent, can be ex-
plained by: i) degradation of precursors to target CECs (Jelic et al.,
2011; Ternes et al., 2004); ii) partitioning to the aqueous phase of
CECs sorbed to the solid phase (Jelic et al., 2011; Ternes et al., 2004);
iii) influent and effluent samples representing different portions of
wastewater, since the samples were collected at the same time but
the WWTPs have different hydraulic retention times (Ort et al., 2010);
iv) concentrations close to the detection limit, which have higher uncer-
tainty; and v) analytical error (Ort et al., 2010).
Previous studies have reported relatively low removal efficiencies
for most pharmaceuticals and personal care products in winter months,
possibly owing to lower rates of microbial activity (Hedgespeth et al.,
2012; Vieno et al., 2005). Degradation is assumed to be a minor factor
and will be significantly reduced at lower temperatures. The negative
removal values reported for some compounds (Gracia-Lor et al., 2012;
Jelic et al., 2011) could be related to this effect. Similar seasonal differ-
ences in removal efficiencies have been reported elsewhere
(Castiglioni et al., 2006; Ferguson et al., 2013; Hijosa-Valsero et al.,
2010), leading to the general conclusion that treatment processes are
more efficient during warmer periods. Another explanation for low or
negative removal efficiencies can be that more water-soluble CECs
(low Kd, low KOW) may partition over time (under well-mixed condi-
tions) to the aqueous phase, resulting in negative removal efficiency.
In the present study, carbamazepine and its metabolites showed
negative removal efficiency, regardless of the treatment applied. The re-
sults concerning carbamazepine persistency and its ubiquitous
occurrence confirm findings in previous studies (Joss et al., 2005). No
significant overall removal was observed for most antibiotics
(sparfloxacin, clindamycin, trimethoprim, erythromycin, azithromycin,
clarithromycin, ciprofloxacin, amoxicillin, sulfamethoxazole, metroni-
dazole and its metabolite) and antidepressants (citalopram and its
metabolite desmethylcitalopram, sertraline, fluoxetine, venlafaxine
and its metabolite desmethylvenlafaxine, oxazepam, mirtazapine, and
Fig. 4. Median removal efficiency of selected chemicals of emerging concern (CECs) with frequency of detection >50% in wastewater samples. D-H-CAR – 10,11-Dihydro-10-
hydroxycarbamazepine (D-H-CAR), BAM – dichlorobenzamide, HCTZ – hydrochlorothiazide, DEET – N,N-diethyl-m-toluamide, DEHPA – di-(2-ethylhexyl)phosphoric acid.
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tional treatment atWWTPs has been reported in several previous stud-
ies (Bendz et al., 2005; Gobel et al., 2007; Kasprzyk-Hordern et al.,
2009). Analysis of the relationship between physiochemical characteris-
tics of individual CECs (Fig. S1 in SI) and removal efficiency using the PLS
model showed no significant correlation (R2X < 0.3) (Fig. S1 in SI). For
example, the structurally similar compounds sotalol and metoprolol
(β blocker) showed similarly poor elimination, but another compound
in this class, atenolol, exhibited much better removal. This is in agree-
ment with the literature, where very few studies have found a correla-
tion between physiochemical characteristics of CECs and removal
efficiency (Rostvall et al., 2018). Thus, more research is needed to better
predict removal efficiencies of CECs during wastewater treatment.
High concentrations of CECswere detected in sludge (Fig. 3), indicat-
ing that CECs can be removed from thewastewater streamvia sludge, as
reported previously (Camacho-Munoz et al., 2012). Kd value, which has
been shown to be a good predictor for removal of CECs in WWTP
(Pomiès et al., 2013), was calculated for 47 CECs (Table S2 in SI). The
Kd value for most compounds showed a significant linear correlation
with KOW and was the best explanatory variable in a PLS plot (R2 =
0.32; p < 0.001, Pearson correlation) (Fig. 5). Previous studies have
discussed the role of the partitioning constant (Luo et al., 2014), sug-
gesting that CECs with log Kd < 2.5 will mainly end up in the aqueous
phase, while those with log Kd > 3.2 are more likely to partition to the
solid phase. However, in this study there was no significant correlationFig. 5. Log partitioning coefficient (log Kd, L/kg) for chemicals of emerging concern (CEC)
in sludge and wastewater (based on 48 CECs and 15 wastewater treatment plants) as a
function of modeled log octanol/water partitioning coefficient (KOW).(R2 = 0.077, p=0.070) between log Kd and removal efficiency (Fig. S1
in SI), which indicates that Kd value is not always a good predictor of re-
moval efficiency. On the other hand, the linear model based on log KOW
presented in this study (Fig. 5) can be used as a simple tool for predic-
tion of Kd values of new CECs and their fate in the aqueous and solid
phase. Partitioning coefficient (log Kd) value is a critical parameter for
prediction and modeling of the fate of individual CECs through WWTP
as reported in a few studies (Luo et al., 2014; Pomiès et al., 2013).
Here we present log Kd values for 47 CECs, information that can be
used in future studies. The log Kd values for individual compounds
ranged between1.3 and 4.5, with ameanof 2.8 and a standard deviation
of 0.83 (coefficient of variation (CV)=30%). TheKd values for individual
CECs were based on a minimum of four WWTPs (mean 13.3 ± 2.6
WWTPs) and the mean standard deviation was 0.36 ± 0.16 log units
(CV = 14 ± 9.4%). This low variation in log Kd values for multiple
WWTP indicates a high-quality assessment and good stability of the pa-
rameters. However, it should be noted that all WWTPs in this study had
a similar (same order of magnitude) influent CEC profile (Figs. 1 and 3)
and the same types of treatment steps, which should be considered
when transferring the results to other WWTP conditions.
3.3. Impact of wastewater treatment effluent on the recipient water system
In surface water samples (upstream or downstream), 122 of the
164 target compounds were detected (Fig. 6, Tables S5 and S8 in
SI). The highest concentration was observed for metformin
(19,000 ng/L), followed by caffeine (3600 ng/L), sulisobenzone
(1700 ng/L), and desmethylvenlafaxine (18,000 ng/L). In addition,
12 CECs (tetraethylene glycol, laureth-5, tributyl citrate acetate,
DEHPA, pyridoxine, metoprolol, tramadol, codeine, citalopram,
lamotrigine, BAM and losartan) were detected with >95% detection
frequency in high concentrations. The frequent detection of these
CECs can be explained by their universal use in many consumer
products. Some of these compounds can be partly removed via natu-
ral attenuation (e.g., photodegradation), while other compounds
(e.g., metoprolol, lamotrigine, and carbamazepine) are resistant to
degradation and persistent in the environment. Metformin is one of
the most frequently detected pharmaceuticals in surface water
worldwide (Briones et al., 2016). Lindim et al. (Lindim et al., 2016)
identified metformin, furosemide, gabapentin, atenolol, and trama-
dol as substances with high emissions to Swedish surface waters,
Fig. 6. Combined concentrations of chemicals of emerging concern (CECs) in recipient water samples. RU – recipient upstream, RD – recipient downstream, NSAIDs – nonsteroidal anti-
inflammatory drugs, PFASs – per- and polyfluoroalkyl substances.
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tion, biodegradation, and photodegradation, CEC concentrations are
typically lower in surface water than in WWTP effluent (Debska
et al., 2004; Ferguson et al., 2013; Kasprzyk-Hordern et al., 2009;
Vieno et al., 2005).
Our results showed that WWTP effluent could be one of the main
sources of CECs in aquatic environments, which is in agreement with
previous findings (Gago-Ferrero et al., 2017; Sörengård et al., 2019). In
general, the concentrations of CECs inwater at the downstream location
were, on average, 50% higher than those upstream of the WWTPs. This
can be explained by the WWTP effluent most likely being a major
point-source input of these compounds to the recipient. These CECs res-
idues may pose a risk to the aquatic environment and/or human health,
so further studies are needed to evaluate their effects on ecosystems.
3.4. Zebrafish embryo toxicity of wastewater and recipient water samples
Water samples from 11 differentWWTPs in Swedenwere evaluated
for lethal, sub-lethal, and behavior effects in early developing zebrafish
embryos. The number of adversely affected zebrafish embryos after
144 hpf of exposure to the different WWTPs samples was generally
low (Table S4 in SI). It is important to note that ecotoxicologically im-
portant chemicals might have been missed during the extraction pro-
cess, compared with toxicological testing of whole water samples. The
most commonly recorded adverse effects were side-lying and edema
of the pericardial sac and the yolk-sac, but no statistically significant dif-
ferences in the number of malformations were recorded for any of the
treatment groups. However, exposure to some of the WWTP samples
resulted in toxicity compared with the respective control group. Expo-
sure to influent samples from both WWTP 9 and WWTP 10 resulted in
100% mortality after only 24 hpf. The survival rate of embryos was
high overall in all other samples from the differentWWTPs. The influent
from WWTP 4 reduced spontaneous movements measured at 24 hpf.
Decreases in heart rate at 48 hpf were recorded for embryos exposed
to both influent and effluent water, and to upstream and downstream
recipient samples, from WWTP 8 (Fig. 7A). As shown in the chemical
analysis, WWTP effluent contains a vast amount of CECs, including
pharmaceuticals, and many of these (e.g., β-blockers) are known to re-
duce heart rate in zebrafish (Sun et al., 2014). Longer time to hatching
was recorded for embryos exposed to influent samples from WWTP 4
(Fig. 7B), and to both influent and effluent samples from WWTP 8
(Fig. 7C). Effects on hatching time may be due to general physiological
stress and reduced health from the total chemical exposure burden.Low concentrations of chemicals might thus stress embryos to hatch
earlier, while high concentrations can negatively affect their overall
health, resulting in delayed hatching or even failure to hatch. The overall
chemical burdenmight also affect swimming behavior. Exposure to the
influent samples from both WWTP 4 and WWTP 15 (Fig. 8) resulted in
reduced swimming distances compared with controls. Neuro-active
pharmaceuticals in sewage water can also contribute to behavior
changes affecting heart rate, hatching, and swimming (Carlsson et al.,
2013; Pohl et al., 2019). Overall, the chemical analyses in the present
study revealed high occurrences of antidepressants, opioids, and stimu-
lant drugs, which can all be causative agents for the observed effects in
zebrafish embryos. However, PLS analysis of relationships between
ZFET and individual CEC concentrations did not show significant corre-
lations (R2X < 0.3). Hence, no individual compound or group of com-
pounds could explain the toxicity in ZFET.
4. Conclusions
A total of 119 contaminants were detected in at least one sample, in
average concentrations ranging fromng/L tomg/L inwater samples and
from ng/g dw to μg/g dw in sludge samples. The most commonly de-
tected CECs in WWTP influent and effluent, sludge, and surface water
samples were industrial chemicals (tetraethylene glycol, laureth-5 and
DEHPA), a personal care product (sulibenzone), pharmaceuticals
(diclofenac, losartan, venlafaxine, lamotrigine, carbamazepine, trama-
dol, fexofenadine, citalopram bicalutamide, metformin), and stimulants
(caffeine and nicotine). Removal of CECs in the WWTPs varied widely
for individual compounds. In general, CECs can be removed via degrada-
tion or sorb onto solids, which can be removed by activated sludge
treatment. However, there is a risk of CECs degrading tomore persistent
and toxic transformation products. There is also a risk of CECs being re-
leased into the environment when sludge is applied on agricultural
land. The CEC concentrations in recipient waters were generally one
order of magnitude lower than those in WWTP effluent. Comparisons
of CEC concentrations in upstream and downstream recipient samples
showed on average 50% higher concentrations downstream of WWTPs
compared with upstream, indicating that WWTP effluent can have a
marked impact on recipient waters. Overall, the results in this study in-
dicate that most WWTPs investigated achieve sufficient removal of
chemicals, given that zebrafish embryos were non-affected by the efflu-
ent and recipient samples. However, observed adverse effects were ob-
served for WWTP 4 andWWTP 8, indicating that potentially toxic CECs
were less efficiently removed in these WWTPs. In addition, constant
Fig. 7. Zebrafish embryo toxicity of wastewater and recipient water samples. (A) Heart
rate (beats per minute) at 48 hpf in zebrafish embryos exposed to water samples from
WWTP 8. Mean hatching time of zebrafish embryos exposed to (B) WWTP 4 and
(C) WWTP 8. RU – recipient upstream, I – wastewater influent, E – wastewater effluent,
RD – recipient downstream.
Fig. 8. Swimming distance of zebrafish embryos exposed to water samples fromWWTP 4
in alternating dark and light periods at 144 h. Data showing total swimming distance
(mm/30 min), swimming distance during dark (mm/15 min), and swimming distance
during light (mm/15 min). RU – recipient upstream, I – wastewater influent, E –
wastewater effluent, RD – recipient downstream.
8 O. Golovko et al. / Science of the Total Environment 754 (2021) 142122release of potentially persistent and bioaccumulative chemicals from
WWTPswarrants attention in terms of effects on aquatic organisms. Fu-
ture studies should therefore focus on long-term investigations of life-
long effects of low-dose exposure to pollutants, which is a more likely
situation for aquatic organisms in recipient waters. Ultimately, ad-
vanced technologies for removal of CECs from wastewater are needed
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